17th International Conference on Fundamental and Applied Aspects of Physical Chemistry (Proceedings, Volume II) (2024) [O-12-P, pp. 631-634]
AUTHOR(S) / AUTOR(I): Marija Vučkovski 
, Ana Filipović , Zdravko Džambaski , Bojan Bondžić and Aleksandra M. Bondžić
Download Full Pdf 
DOI: 10.46793/Phys.Chem24II.631V
ABSTRACT / SAŽETAK:
The potential therapeutic applications of metal chelation in the treatment of Alzheimer’s disease have attracted significant attention due to the involvement of metal ion dysregulation in the pathology of the disease. This study investigates the chelation properties of a novel compound, tetrahydroisoquinoline-derivatized quercetin, THIQ-Q, with Cu²⁺, Zn²⁺, and Fe²⁺ ions, aiming to evaluate its efficacy as a potential treatment for Alzheimer’s disease. Using UV/Vis spectroscopy we analysed the binding interactions and stoichiometry of the compound with these metal ions. Obtained results indicate that the newly synthesized compound, THIQ-Q, forms 2:1 complex with Cu²⁺ and Zn²⁺ while 1:1 complex is formed with Fe2+, which indicate its potential as a therapeutic agent in managing metal ion dysregulation in Alzheimer’s disease.
KEYWORDS / KLJUČNE REČI:
ACKNOWLEDGEMENT / PROJEKAT:
This work was supported by the Ministry of Science, Technological Development, and Innovation of the Republic of Serbia (Agreement No. 451-03-66/2024-03/200017 and 451-03-66/2024- 03/200026).
REFERENCES / LITERATURA:
- Y. Liu, M. Nguyen, A. Robert, B. Meunier, Acc. Chem. Res., 52 (2019) 2026–2035.
- M. Leopoldini, N. Russo, S. Chiodo, M. Toscano, J. Agric. Food Chem., 54 (2006) 6343–6351.
- D. Jovanović, A. Filipović, G. Janjić, T. Lazarević-Pašti, Z. Džambaski, B. P. Bondžić, A. M. Bondžić, Int. J. Mol. Sci., 25 (2024) 1033.
- Sh. N. Zhurakulov, D. A. Narbutaeva, A. M. Karakulova, F. M. Tursunkhodzhaeva, V. I. Vinogradova, Chem. Nat. Compd., 59 (2023) 655–661.
- A. Moncomble, C. Falantin, J. P. Cornard, J. Phys. Chem. B, 122 (2018) 8943–8951
- Y. Liu and M. Guo, Molecules, 20 (2015) 8583–8594.